US HB7535 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 5 2024 - 25% progression
Action: 2024-03-08 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 5 2024 - 25% progression
Action: 2024-03-08 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.
Title
Prescription Drug Supply Chain Pricing Transparency Act
Sponsors
Rep. Yadira Caraveo [D-CO] | Rep. Tracey Mann [R-KS] |
History
Date | Chamber | Action |
---|---|---|
2024-03-08 | House | Referred to the Subcommittee on Health. |
2024-03-05 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2024-03-05 | House | Introduced in House |
Same As/Similar To
SB2973 (Related) 2023-12-07 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 266.
SB2198 (Same As) 2023-06-22 - Read twice and referred to the Committee on Finance.
SB2198 (Same As) 2023-06-22 - Read twice and referred to the Committee on Finance.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/7535/all-info |
Text | https://www.congress.gov/118/bills/hr7535/BILLS-118hr7535ih.pdf |